BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 24247297)

  • 1. Honokiol inhibits U87MG human glioblastoma cell invasion through endothelial cells by regulating membrane permeability and the epithelial-mesenchymal transition.
    Joo YN; Eun SY; Park SW; Lee JH; Chang KC; Kim HJ
    Int J Oncol; 2014 Jan; 44(1):187-94. PubMed ID: 24247297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Honokiol exerts an anticancer effect in T98G human glioblastoma cells through the induction of apoptosis and the regulation of adhesion molecules.
    Jeong JJ; Lee JH; Chang KC; Kim HJ
    Int J Oncol; 2012 Oct; 41(4):1358-64. PubMed ID: 22895699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversion of malignant phenotypes of human glioblastoma cells by β-elemene through β-catenin-mediated regulation of stemness-, differentiation- and epithelial-to-mesenchymal transition-related molecules.
    Zhu T; Li X; Luo L; Wang X; Li Z; Xie P; Gao X; Song Z; Su J; Liang G
    J Transl Med; 2015 Nov; 13():356. PubMed ID: 26563263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mechanism of honokiol-induced intracellular Ca(2+) rises and apoptosis in human glioblastoma cells.
    Liang WZ; Chou CT; Chang HT; Cheng JS; Kuo DH; Ko KC; Chiang NN; Wu RF; Shieh P; Jan CR
    Chem Biol Interact; 2014 Sep; 221():13-23. PubMed ID: 25106108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of honokiol against oxidized LDL-induced cytotoxicity and adhesion molecule expression in endothelial cells.
    Ou HC; Chou FP; Lin TM; Yang CH; Sheu WH
    Chem Biol Interact; 2006 May; 161(1):1-13. PubMed ID: 16580656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer.
    Liu H; Zang C; Emde A; Planas-Silva MD; Rosche M; Kühnl A; Schulz CO; Elstner E; Possinger K; Eucker J
    Eur J Pharmacol; 2008 Sep; 591(1-3):43-51. PubMed ID: 18588872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Honokiol inhibits EMT-mediated motility and migration of human non-small cell lung cancer cells in vitro by targeting c-FLIP.
    Lv XQ; Qiao XR; Su L; Chen SZ
    Acta Pharmacol Sin; 2016 Dec; 37(12):1574-1586. PubMed ID: 27593221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Honokiol thwarts gastric tumor growth and peritoneal dissemination by inhibiting Tpl2 in an orthotopic model.
    Pan HC; Lai DW; Lan KH; Shen CC; Wu SM; Chiu CS; Wang KB; Sheu ML
    Carcinogenesis; 2013 Nov; 34(11):2568-79. PubMed ID: 23828905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal ZEB1-Driven Mesenchymal Transition Promotes Targetable Oncologic Antiangiogenic Therapy Resistance.
    Chandra A; Jahangiri A; Chen W; Nguyen AT; Yagnik G; Pereira MP; Jain S; Garcia JH; Shah SS; Wadhwa H; Joshi RS; Weiss J; Wolf KJ; Lin JG; Müller S; Rick JW; Diaz AA; Gilbert LA; Kumar S; Aghi MK
    Cancer Res; 2020 Apr; 80(7):1498-1511. PubMed ID: 32041837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Honokiol inhibits breast cancer cell metastasis by blocking EMT through modulation of Snail/Slug protein translation.
    Wang WD; Shang Y; Li Y; Chen SZ
    Acta Pharmacol Sin; 2019 Sep; 40(9):1219-1227. PubMed ID: 31235819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis.
    Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G
    Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Honokiol inhibits sphere formation and xenograft growth of oral cancer side population cells accompanied with JAK/STAT signaling pathway suppression and apoptosis induction.
    Huang JS; Yao CJ; Chuang SE; Yeh CT; Lee LM; Chen RM; Chao WJ; Whang-Peng J; Lai GM
    BMC Cancer; 2016 Mar; 16():245. PubMed ID: 27012679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Honokiol confers immunogenicity by dictating calreticulin exposure, activating ER stress and inhibiting epithelial-to-mesenchymal transition.
    Liu SH; Lee WJ; Lai DW; Wu SM; Liu CY; Tien HR; Chiu CS; Peng YC; Jan YJ; Chao TH; Pan HC; Sheu ML
    Mol Oncol; 2015 Apr; 9(4):834-49. PubMed ID: 25619450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Bevacizumab-induced Epithelial-Mesenchymal Transition by BATF2 Overexpression Involves the Suppression of Wnt/β-Catenin Signaling in Glioblastoma Cells.
    Huang W; Zhang C; Cui M; Niu J; Ding W
    Anticancer Res; 2017 Aug; 37(8):4285-4294. PubMed ID: 28739720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of epithelial and mesenchymal proteins in a panel of prostate cancer cell lines.
    Murali AK; Norris JS
    J Urol; 2012 Aug; 188(2):632-8. PubMed ID: 22704442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paeoniflorin Inhibits Migration and Invasion of Human Glioblastoma Cells via Suppression Transforming Growth Factor β-Induced Epithelial-Mesenchymal Transition.
    Wang Z; Liu Z; Yu G; Nie X; Jia W; Liu RE; Xu R
    Neurochem Res; 2018 Mar; 43(3):760-774. PubMed ID: 29423667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.
    Tsai JH; Hsu LS; Lin CL; Hong HM; Pan MH; Way TD; Chen WJ
    Toxicol Appl Pharmacol; 2013 Nov; 272(3):746-56. PubMed ID: 23921149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor binding protein-4 (IGFBP-4) is a novel anti-angiogenic and anti-tumorigenic mediator secreted by dibutyryl cyclic AMP (dB-cAMP)-differentiated glioblastoma cells.
    Moreno MJ; Ball M; Andrade MF; McDermid A; Stanimirovic DB
    Glia; 2006 Jun; 53(8):845-57. PubMed ID: 16586492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.
    Tse AK; Wan CK; Shen XL; Yang M; Fong WF
    Biochem Pharmacol; 2005 Nov; 70(10):1443-57. PubMed ID: 16181613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osthole inhibits insulin-like growth factor-1-induced epithelial to mesenchymal transition via the inhibition of PI3K/Akt signaling pathway in human brain cancer cells.
    Lin YC; Lin JC; Hung CM; Chen Y; Liu LC; Chang TC; Kao JY; Ho CT; Way TD
    J Agric Food Chem; 2014 Jun; 62(22):5061-71. PubMed ID: 24828835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.